273 related articles for article (PubMed ID: 24863691)
1. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
2. miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment.
Piatopoulou D; Avgeris M; Marmarinos A; Xagorari M; Baka M; Doganis D; Kossiva L; Scorilas A; Gourgiotis D
Br J Cancer; 2017 Sep; 117(6):801-812. PubMed ID: 28787435
[TBL] [Abstract][Full Text] [Related]
3. Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group.
Termuhlen AM; Smith LM; Perkins SL; Lones M; Finlay JL; Weinstein H; Gross TG; Abromowitch M
Pediatr Blood Cancer; 2012 Dec; 59(7):1229-33. PubMed ID: 22488718
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group.
Salzer WL; Devidas M; Carroll WL; Winick N; Pullen J; Hunger SP; Camitta BA
Leukemia; 2010 Feb; 24(2):355-70. PubMed ID: 20016527
[TBL] [Abstract][Full Text] [Related]
5. Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.
Hayashi RJ; Winter SS; Dunsmore KP; Devidas M; Chen Z; Wood BL; Hermiston ML; Teachey DT; Perkins SL; Miles RR; Raetz EA; Loh ML; Winick NJ; Carroll WL; Hunger SP; Lim MS; Gross TG; Bollard CM
J Clin Oncol; 2020 Sep; 38(26):3062-3070. PubMed ID: 32552472
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors.
Park SR; Kim JH; Kim DY; Lee S; Lee SY; Choi IS; Yoon SS; Park S; Kim BG; Kim NK
Korean J Intern Med; 2003 Mar; 18(1):21-8. PubMed ID: 12760264
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic analysis of childhood T-lymphoblastic lymphoma treated with leukemia regimen].
Hou SM; Shao JB; Li H; Zhang N; Zhu JS; Wang D; Fu P
Zhongguo Dang Dai Er Ke Za Zhi; 2024 May; 26(5):469-475. PubMed ID: 38802906
[TBL] [Abstract][Full Text] [Related]
8. Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.
Chauvenet AR; Martin PL; Devidas M; Linda SB; Bell BA; Kurtzberg J; Pullen J; Pettenati MJ; Carroll AJ; Shuster JJ; Camitta B
Blood; 2007 Aug; 110(4):1105-11. PubMed ID: 17442849
[TBL] [Abstract][Full Text] [Related]
9. [Interim results of a multicenter cohort study for Chinese Children Leukemia Group-acute lymphoblastic leukemia 2018 regimen].
Chinese Children Leukemia Group
Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):874-880. PubMed ID: 37803853
[No Abstract] [Full Text] [Related]
10. Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.
Salzer WL; Burke MJ; Devidas M; Chen S; Gore L; Larsen EC; Borowitz M; Wood B; Heerema NA; Carroll AJ; Hilden JM; Loh ML; Raetz EA; Winick NJ; Carroll WL; Hunger SP
Cancer; 2018 Mar; 124(6):1150-1159. PubMed ID: 29266189
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and prognostic factors of the chemotherapy regimen of CCLG-ALL-2008 on pediatric acute lymphoblastic leukemia with ETV6-RUNX1 rearrangement].
Liu F; Chen XJ; Guo Y; Yang WY; Chen X; Zhang XY; Zhang RR; Ren YY; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):896-902. PubMed ID: 33333691
[No Abstract] [Full Text] [Related]
12. Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial.
Domenech C; Suciu S; De Moerloose B; Mazingue F; Plat G; Ferster A; Uyttebroeck A; Sirvent N; Lutz P; Yakouben K; Munzer M; Röhrlich P; Plantaz D; Millot F; Philippet P; Dastugue N; Girard S; Cavé H; Benoit Y; Bertrandfor Y;
Haematologica; 2014 Jul; 99(7):1220-7. PubMed ID: 24727815
[TBL] [Abstract][Full Text] [Related]
13. Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.
Gupta S; Teachey DT; Chen Z; Rabin KR; Dunsmore KP; Larsen EC; Maloney KW; Mattano LA; Winter SS; Carroll AJ; Heerema NA; Borowitz MJ; Wood BL; Carroll WL; Raetz EA; Winick NJ; Loh ML; Hunger SP; Devidas M
Cancer; 2022 May; 128(9):1863-1870. PubMed ID: 35201611
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and prognostic analysis of children and adolescents over 10 years of age with acute lymphoblastic leukemia].
Wu J; Lu AD; Zhang LP
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jun; 19(6):614-619. PubMed ID: 28606225
[TBL] [Abstract][Full Text] [Related]
15. Improved prognosis for older adolescents with acute lymphoblastic leukemia.
Pui CH; Pei D; Campana D; Bowman WP; Sandlund JT; Kaste SC; Ribeiro RC; Rubnitz JE; Coustan-Smith E; Jeha S; Cheng C; Metzger ML; Bhojwani D; Inaba H; Raimondi SC; Onciu M; Howard SC; Leung W; Downing JR; Evans WE; Relling MV
J Clin Oncol; 2011 Feb; 29(4):386-91. PubMed ID: 21172890
[TBL] [Abstract][Full Text] [Related]
16. MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.
Hayashi RJ; Hermiston ML; Wood BL; Teachey DT; Devidas M; Chen Z; Annett RD; Asselin BL; August K; Cho S; Dunsmore KP; Freedman JL; Galardy PJ; Harker-Murray P; Horton TM; Jaju A; Lam A; Messinger YH; Miles RR; Okada M; Patel S; Schafer ES; Schechter T; Shimano KA; Singh N; Steele A; Sulis ML; Vargas SL; Winter SS; Wood C; Zweidler-McKay PA; Loh ML; Hunger SP; Raetz EA; Bollard CM; Allen CE
Blood; 2024 May; 143(20):2053-2058. PubMed ID: 38457359
[TBL] [Abstract][Full Text] [Related]
17. Improved Outcome for ALL by Prolonging Therapy for
Pieters R; de Groot-Kruseman H; Fiocco M; Verwer F; Van Overveld M; Sonneveld E; van der Velden V; Beverloo HB; Bierings M; Dors N; de Haas V; Hoogerbrugge P; Van der Sluis I; Tissing W; Veening M; Boer J; Den Boer M
J Clin Oncol; 2023 Sep; 41(25):4130-4142. PubMed ID: 37459571
[TBL] [Abstract][Full Text] [Related]
18. Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.
Jenkinson S; Koo K; Mansour MR; Goulden N; Vora A; Mitchell C; Wade R; Richards S; Hancock J; Moorman AV; Linch DC; Gale RE
Leukemia; 2013 Jan; 27(1):41-7. PubMed ID: 22814294
[TBL] [Abstract][Full Text] [Related]
19. Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia.
Gutierrez A; Dahlberg SE; Neuberg DS; Zhang J; Grebliunaite R; Sanda T; Protopopov A; Tosello V; Kutok J; Larson RS; Borowitz MJ; Loh ML; Ferrando AA; Winter SS; Mullighan CG; Silverman LB; Chin L; Hunger SP; Sallan SE; Look AT
J Clin Oncol; 2010 Aug; 28(24):3816-23. PubMed ID: 20644084
[TBL] [Abstract][Full Text] [Related]
20. Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia--Comparison among Different Treatment Strategies.
Matloub Y; Stork L; Asselin B; Hunger SP; Borowitz M; Jones T; Bostrom B; Gastier-Foster JM; Heerema NA; Carroll A; Winick N; Carroll WL; Camitta B; Devidas M; Gaynon PS
Pediatr Blood Cancer; 2016 Feb; 63(2):255-61. PubMed ID: 26485054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
